Gain Therapeutics, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q2 2021 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Gain Therapeutics, Inc. annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q2 2021 to Q1 2023.
- Gain Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2023 was $55.2K, a 47% increase year-over-year.
- Gain Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $55.2K, a 58.4% decline from 2022.
- Gain Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $133K, a 0.96% decline from 2021.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)